Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is 0.20 MM.
- The operating income for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -41.13 MM.
- The net income for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -53.86 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2024-12-31 | 0.20 | -41.13 | -53.86 |
2024-09-30 | 1.15 | -47.15 | -55.49 |
2024-06-30 | 2.10 | -53.18 | -57.11 |
2024-03-31 | 1.46 | -53.36 | -114.86 |
2023-12-31 | 0.82 | -53.55 | -172.60 |
2023-09-30 | 0.52 | -50.40 | -280.34 |
2023-06-30 | 1.23 | -47.25 | -388.09 |
2023-03-31 | 1.29 | -45.66 | -314.45 |
2022-12-31 | 0.32 | -44.06 | -240.81 |
2022-09-30 | 0.43 | -45.70 | -136.27 |
2022-06-30 | 1.13 | -47.34 | -31.73 |
2022-03-31 | 0.86 | -48.80 | -63.26 |
2021-12-31 | 0.00 | -50.27 | -94.80 |
2020-12-31 | 1.84 | -40.65 | -74.82 |
Income Statement: EPS
- The earnings per share basic for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -52.80.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2024-12-31 | -52.80 | |
2024-09-30 | -57.27 | -57.61 |
2024-06-30 | -62.23 | -62.95 |
2024-03-31 | -138.22 | -138.62 |
2023-12-31 | -231.99 | |
2023-09-30 | -473.63 | -449.60 |
2023-06-30 | -95.48 | -88.48 |
2023-03-31 | -78.87 | -75.30 |
2022-12-31 | -844.95 | |
2022-09-30 | -34.51 | -37.88 |
2022-06-30 | -13.85 | -25.47 |
2022-03-31 | -19.98 | -24.18 |
2021-12-31 | -337.27 | |
2020-12-31 | -20.70 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -28.74 MM.
- The cash from investing activities for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is 5.98 MM.
- The cash from financing activities for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is 0.47 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2024-12-31 | -28.74 | 5.98 | 0.47 |
2024-09-30 | -31.77 | 16.67 | 4.29 |
2024-06-30 | -34.80 | 27.35 | 8.10 |
2024-03-31 | -39.00 | 24.36 | 14.66 |
2023-12-31 | -43.21 | 21.36 | 21.23 |
2023-09-30 | -45.35 | 13.17 | 19.16 |
2023-06-30 | -47.49 | 4.97 | 17.10 |
2023-03-31 | -45.16 | 17.01 | 8.40 |
2022-12-31 | -42.82 | 29.05 | -0.29 |
2022-09-30 | -41.15 | 30.34 | -0.68 |
2022-06-30 | -39.48 | 31.64 | -1.06 |
2022-03-31 | -41.40 | -3.66 | -1.35 |
2021-12-31 | -43.31 | -38.95 | -1.64 |
2020-12-31 | -35.68 | 2.33 | 125.51 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2020-12-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2020-12-31 |
Management Effectiveness
- The roa for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -0.97.
- The roe for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -1.31.
- The roic for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -5.77.
- The croic for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -2.39.
- The ocroic for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -3.08.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2024-12-31 | -0.97 | -1.31 | -5.77 | -2.39 | -3.08 |
2024-09-30 | -1.00 | -1.35 | -5.94 | -1.16 | -3.40 |
2024-06-30 | -1.61 | -2.06 | -4.44 | 0.00 | -1.51 |
2024-03-31 | -2.26 | -3.73 | -0.01 | -0.93 | |
2023-12-31 | -3.67 | -6.06 | -0.28 | -0.98 | |
2023-09-30 | -3.90 | -6.73 | -0.44 | -0.82 | |
2023-06-30 | -3.90 | -6.73 | -0.44 | -0.82 | |
2023-03-31 | -3.16 | -5.46 | -0.34 | -0.78 | |
2022-12-31 | -1.10 | -2.11 | -0.18 | -0.64 | |
2022-09-30 | -1.10 | -2.11 | -0.18 | -0.64 | |
2022-06-30 | -0.19 | -0.36 | -0.10 | -0.45 | |
2022-03-31 | -0.37 | -0.72 | -0.53 | -0.47 | |
2021-12-31 | -0.56 | -0.86 | -0.76 | -0.39 | |
2020-12-31 | -0.47 | 0.58 | -0.23 |
Gross Margins
- The gross margin for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is 1.00.
- The net margin for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -272.01.
- The operating margin for Apollomics, Inc. - Equity Warrant as of December 31, 2024 is -207.71.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2024-12-31 | 1.00 | -272.01 | -207.71 |
2024-09-30 | 1.00 | -48.27 | -41.02 |
2024-06-30 | 1.00 | -78.62 | -36.53 |
2024-03-31 | 1.00 | -53.45 | -15.98 |
2023-12-31 | 1.00 | -540.68 | -97.20 |
2023-09-30 | 1.00 | -1,796.70 | -218.73 |
2023-06-30 | 1.00 | -1,796.70 | -218.73 |
2023-03-31 | 1.00 | -1,166.79 | -169.41 |
2022-12-31 | 1.00 | -110.43 | -37.04 |
2022-09-30 | 1.00 | -110.43 | -37.04 |
2022-06-30 | 1.00 | -28.11 | -41.93 |
2022-03-31 | 1.00 | -73.65 | -56.81 |
2021-12-31 | 1.00 | -160.95 | -85.35 |
2020-12-31 | 1.00 | -40.71 | -22.11 |
Identifiers and Descriptors
Central Index Key (CIK) |